For more information and to register please email c.d.gwenin@bangor.ac.uk or leigh.jones@bangor.ac.uk
Table of Content Page FOREWORD
4
ACKNOWLEDGEMENTS
5
WELCOME
6
BIOSENSORS WORKSHOP
7
NRN - BACKGROUND
8
CALIN - BACKGROUND
10
PROGRAMME - Day 1
12
PROGRAMME - Day 2
14
2
SPEAKERS
Page
Dr. Guido Drago
16
Dr. Jenna Bowen
17
Dr. Paul Morgan
18
Dr. James Sheridan
19
Dr. Lynne Grundy
20
Prof. Dyfrig Hughes
21
Dr. Stephen Hughes
22
Dr. Lewis Francis
23
Prof. David J Snowden
24
Dr. Chris Tyson
25
Prof. Owen J. Guy
26
Prof. John Draper
27
Mr. Steven Taaffe
28
Dr. Paul Galvin
29
Dr. Stephen Oakeshott
30
Dr. Ann Sudder
31
Dr. Martin Champion
32
NOTES
33
3
Foreword Professor David Shepherd Pro-Vice Chancellor for Research and Enterprise, Bangor University
Dear Participants I am delighted to welcome you to Bangor University, the host of this Life Sciences Research Network Wales and INTERREG funded Biosensors Workshop. This workshop is aimed at highlighting the novel research that is taking place in the area of health related biosensors. Biosensors are of paramount importance for the effective use of novel therapeutic drugs; this meeting will bring together researchers from across Wales both to present their research and to meet global researchers in the field. I wish you all an exciting and profitable day. David Shepherd
4
Acknowledgements Conference Organising Committee: Dr. Chris Gwenin, Dr. Leigh Jones, Tracey Roberts, Siobhan Jones, Dr. Zoe Bentham and Rachel Ashton. With additional support from the administrative and technical staff and many of our postgraduate students. The committee would also like to thank all the presenters for not only presenting but for their help with the organisation.
Gratefully supported by the Life Sciences Research Network Wales and the CALIN INTEREG Programme
5
Welcome to Bangor University
Opening its doors in 1884, the University was founded as the University College of North Wales as a direct result of a campaign in the late nineteenth century for higher education provision in Wales. An important feature of its foundation was the voluntary contributions made by local people, including farmers and quarrymen, from their weekly wages over
a period of time. In 1893 the University of Wales, Bangor became one of the three original constituent colleges of the University of Wales. Today we have over 10,000 students and 2,000 members of staff. The School of Chemistry at Bangor has a long and distinguished history over 130 years. It was one of the founding schools of the University College of North Wales (now Bangor University) and has a proud tradition of excellent chemists both working in, and being trained at, the School. The School of Chemistry offers a wide range of undergraduate courses, including its flagship MChem programmes. Research work in the school is
of the highest quality and covers traditional areas of organic, inorganic and physical chemistry together with the newer areas of computational, environmental, materials and biological chemistry.
6
Biosensors Workshop This workshop is aimed at highlighting the novel research that is taking place in the area of health related biosensors. Biosensors are of paramount importance for the effective use of novel therapeutic drugs; as such this meeting will bring together researchers from across Wales both to present their research and to meet global researchers in the field. The research area of biosensors has changed dramatically in the last few decades, with even greater changes being anticipated in the near future. In order for the research into novel biosensors to be effective it is imperative to include commercial and clinical input from an early stage. Hence this workshop will draw together academics, clinicians and companies, all of which will present and form a North Wales hub of expertise with global reach. The workshop will pull together experts in the field of biosensors with the ambition to generate new research collaborations and future funding applications. Biosensors are a first line tool in monitoring the effective use of drug treatment and the prevention of unnecessary drug use, which often leads to increased patient drug resistance and detrimental health effects on the patient.
Gratefully supported by the Life Sciences Research Network Wales and the CALIN INTEREG Programme
7
NRN background Background With an increasingly ageing population and a number of major drugs coming off patent, there is a pressing need to develop new drugs and therapeutic agents that address un-met medical needs. The Life Sciences Research Network was established to bring together researchers from across Wales and provide a platform for engaging with companies and research organisations from across the World to develop better science to support new drug discovery. The Need Innovations in health sciences have resulted in dramatic changes in our ability to manage human disease and improve the quality of life. Unquestionably, a major element of this is pharmaceutical development. However, despite increasing spend (2010, ca $85Bn on R&D) by the pharmaceutical industry, new drug approvals show a steady downward trend as compared to 15 years ago. The inverse of this, the cost per new drug, shows a steady increase; the Association of the British Pharmaceutical Industry now estimate a cost per new drug (a New Chemical Entity) of £1.15Bn and an average time from target identification to approval of 12-14 years. The aim of the Network is to bring together academic researchers from across Wales to form a critical mass of research excellence which can more effectively compete for research funding and engage with external organisations. Rather than focus on a particular therapeutic area, the Network will support research excellence in a broad range of scientific disciplines which meet the Network’s investment criteria. Sêr Cymru The Welsh Government has committed up to £50 million to enhance and build upon the research capability in Wales, to attract world-leading scientists and their teams to Wales and to support the establishment of a collaborative National Research Network in each of the three “Grand Challenge” research areas identified in the “Science for Wales” strategy: • Advanced engineering and materials • Life sciences and health • Low carbon, energy and environment
8
NRN background Kathryn Evans Project Manager Life Sciences Research Network Wales Contact details Telephone +44 (0)2920 876433 Email evansKA6@cardiff.ac.uk
Kathryn is Project Manager of the Life Sciences Research Network Wales, one of 3 National Research Networks within the SĂŞr Cymru scheme, launched by Welsh Government to enhance and build on the research capacity in Wales. She is responsible for the day-to-day running of the Network, working at the interface between academia and other stakeholders.
Kathryn has worked at Cardiff University for 10 years in a variety of research management roles, on projects funded by Welsh Government to increase research capacity across Wales. Projects included the Children & Young People’s Research Network and the Microbiology and Infection Translational Research Group at the School of Medicine. She was also Institute Manager for the Sustainable Places Research Institute at Cardiff University. Prior to working for Cardiff University, she worked as a Research Manager for Children in Wales and was Marketing and Fundraising Manager for Save the Children Wales.
9
CALIN background Connecting your business to the knowledge & technology resources you need The Celtic Advanced Life Science Innovation Network (CALIN) is an IrelandWales INTERREG operation that is connecting small-medium enterprises (SMEs) in the Life Science sector with world leading Higher Education Institutions (HEIs) to deliver economic benefit. Funded by the Ireland Wales 2014-2020 programme through the European Regional Development Fund, CALIN has been granted €9.3m, which is further financed by €2.6m from participating institutes. Providing access to cutting edge technology and expertise By uniting a dynamic, cross-border and inter-disciplinary knowledge base, CALIN connects 6 HEIs in Ireland and Wales and the multinational firms, Unilever and GE Healthcare to SMEs across the region. The six higher education institutes involved in CALIN are: Swansea University; University College Dublin; Bangor University; Cardiff University; Tyndall National Institute-Cork; National University of Ireland, Galway. CALIN aims CALIN provides a platform for industry in Ireland and Wales to drive innovation in advanced life sciences and achieve novel healthcare solutions by combining Clinical Need & Commercial Opportunity. The aims of CALIN can be summarised in six key points: To build a network of world-leading HEIs working in partnership with healthcare providers, local SMEs and multinational industries To promote a cross-border collaborative approach to industry-driven innovation To link Irish and Welsh SMEs into the wider network To create new life science products, processes and services to improve healthcare Deliver specialised skilled scientific personnel to address current skills deficit
10
CALIN background
Dr. Gareth Healey CALIN Project Manager Medicine Telephone: +44 1792606474 Email: g.d.healey@swansea.ac.uk
Gareth is a Project Manager with extensive experience from academic, industry and government research institutes. Specialising in nanomedicine and advanced therapeutic development, he has been extensively involved in the development of novel therapeutics for asthma, infectious diseases and cancer throughout his career, and successfully delivered several multi-institution, international projects.
Gareth is currently managing the delivery of a EUR 12M INTERREG ERDF funded operation: the Celtic Advanced Life Science Innovation Network (CALIN).
11
Programme - Day 1 Day 1 - 4th of September 2017 Registration: 11:30
Registration & Networking
Welcome: 12:30
Prof. David Shepherd
Pro-Vice Chancellor for Research and Enterprise, Bangor University
12:40
Dr. Gareth Healey
CALIN project manager
12:50
Kathryn Evans
Project Manager, Life Sciences Research Network Wales
Companies: 13:00
Dr. Guido Drago
Life Science Specialist, Perpetuus Carbon
Graphene Biosensors, where are we now?
13:20
Dr. Jenna Bowen
Cotton Mouton, Diagnostics
Magneto-optical diagnostics 13:40
Dr. Paul Morgan
Managing Director of Biovici
Research, Development and Commercialisation Considerations for SMEs 14:00
Lunch & Networking
Networks: 15:00
Dr. James Sheridan
Director, BIC-innovation
Developments in Produce, Product, Technology & Services for Healthy Ageing & Wellbeing
12
Day 1 - 4th of September 2017 Networks: 15:20
Dr. Lynne Grundy
Research & Development Facilitator, Betsi Cadwaladr University Health Board Welcoming commercial research in BCUHB Clinicians: 15:40 Prof. Dyfrig Hughes Bangor University Betsi Cadwaladr, University Health Board Evidential standards for clinical & cost-effectiveness for NHS adoption 16:00 Dr. Stephen Hughes The North Wales & North West Urological, Research Centre An Innovative Approach to research and collaborative working: The North Wales & North West Urological Research Centre, Betsi Cadwaladr, University Health Board 16:20 Dr. Lewis Francis Senior Lecturer, Swansea University Medical School Multiplex-based biosensing; flexible monitoring of the disease landscape 16:40 Wine & Networking 19:00 Dinner Guest presentations by: Prof. David Snowden The Cynefin Centre for Applied Complexity, Bangor University Human sensors: who owns the power of interpretation? Dr. Chris Tyson Aparito Digital Health – Beyond the Hype
13
Programme - Day 2 Day 2 - 5th of September 2017 09:00
Dr. Leigh Jones
Universities: 09:10 Prof. Owen J. Guy
Professor in Nanotechnology College of Engineering, Swansea University
Lab-on a chip graphene biosensor diagnosis 09:30
Prof. John Draper
IBERS, Aberystwyth University
Biomarker technology associated with metabolomics (mass spectrometry and machine learning) analysis of urine and blood samples. 9:50
Mr. Steven Taaffe
School of Chemistry Bangor University
A lateral flow device for the 21st century 10:10
Dr. Paul Galvin
Head of Life Sciences Interface Group, Tyndall National Institute
Advanced sensor systems for personalised, predictive, participatory and preventative medicine 10:30 Coffee and Networking
14
Day 2 - 5th of September 2017
Funding: 11:30
Dr. Stephen Oakeshott
Programme Manager Translational Research, Medical Research Council
MRC funding opportunities for device development 11:40
Dr. Ann Sudder
Welsh Government Department for Economy Science & Transport
SMART Suite - Commercialisation through R&D 12:00 Dr. Martin Champion
Portfolio Manager, Medical devices EPSRC
EPSRC Healthcare Technologies Theme and Investigator led call 12:30 Lunch & Networking
15
Speakers
Dr. Guido Drago Life Science Specialist Perpetuus Carbon Technologies Contact details Telephone +44 (0)1633 973 012 Email guidodrago@perpetuuscarbon.com
Dr. Guido A. Drago, graduated from University College London with a Ph.D. in Genetics in 1992. He carried out his postdoctoral training in Cardiac Biochemistry at the University of Leeds and the University of Maryland (USA). He joined Applied Enzyme Technology Ltd.(AET), in 1999 as a research officer and became Managing Director of AET in 2001. In 2005 he won a scholarship in Executive Business Marketing Strategy at the Kellogg Graduate School of Management. He became Director of Gwent Electronic Materials Ltd., part of the Gwent Group in 2012. In 2015 he moved to Perpetuus
Carbon
Technologies
Ltd.
to
head
up
a
new
biosensor
department tasked with the development of novel sensors based on graphene like materials. His technical expertise includes the stabilisation and immobilisation of biological molecules such as enzymes, peptides, antibodies
and
DNA
fragments
used
in
the
construction
of
novel
electrochemical and optical biosensors. Presentation title: Graphene Biosensors, where are we now?
16
Speakers
Dr. Jenna Bowen Co-founder / Project Manager of Cotton Mouton Diagnostics Contact details Telephone 029 20 524260 / 07732 782381 Email BowenJL2@cardiff.ac.uk
Dr. Jenna Bowen is co-founder of Cotton Mouton Diagnostics (CMD) and a lecturer at the Cardiff School of Pharmacy and Pharmaceutical Sciences. A Pharmacist by training, Jenna co-founded CMD with colleagues from Cardiff and Exeter Universities in late 2014 to deliver an
innovative diagnostic technology to the healthcare sector. Initially developed and field-tested as a malaria diagnostic, the CMD team are transforming their magneto-optical platform to bring about a paradigm shift in the diagnosis of sepsis; a condition that kills one person every few seconds and for which current diagnostic strategies are limited. CMD’s technology is affordable, reliable and critically maintains sensitivity under challenging conditions to deliver results in less than 15 minutes.
Presentation title: Magneto-optical diagnostics
17
Speakers Paul Morgan Managing Director Contact details Telephone +44(0)7714029926 paul.morgan@biovici.com; gareth.morgan@biovici.com
Paul Morgan—Experienced in company development from start-up to multi-million status. Has experience of a wide range of Industries and has held several board level appointments in FTSE 100 technology companies to manage and deliver substantial profits. Extensive knowledge of Managing
New
Technology
product
launches
from
concept
to
commercialisation including a start-up to AIM listing in 12 months. Gareth
Morgan—BEng (1st Hons) Project management experience
gained in London and Dubai. Has worked on many demanding projects for prestigious clients including Sheikhs. Experience gained working with a UK based nanotechnology company, commercialising nanomaterials. Managed a team to develop, manufacture, globally certify diagnostic tools for the automotive industry. Has helped win and manage multiple UK technology grants. Biovici Ltd—Biovici is currently developing next generation of Point-ofCare diagnostic devices for unmet needs for use in the wellbeing,
veterinary and medical markets. Presentation title: Research, Development and Commercialisation Considerations for SMEs
18
Speakers
Dr. James Sheridan Director, BIC-innovation Contact details Telephone +44 (0)1248 671 101 Email James.Sheridan@bic-innovation.com James Sheridan is a Director of BIC Innovation Ltd of Bangor, with over 25 years in commercial business management and product development. He was Sales Director of a Liverpool based specialist Orthopaedic (Orthotics
and
Prosthetics)
and
Rehabilitation
products
supplier,
developing products for Diabetes and Sports Biomechanics. James delivers a number of programmes in North Wales including
Enterprise
Europe Network and Innovate 2 Succeed for Innovate UK contract. James is Portfolio Manager for the pan European EIT Health FACET programme, which is developing a platform to enable clinical and technology support in the Frailty and Sarcopenia sector. He is working with companies and universities with Produce, Product, Technology and Service developments to support Healthy Ageing and Wellbeing through FACET. Presentation title: Developments in Produce, Product, Technology and Services for Healthy Ageing and Wellbeing
19
Speakers Dr. Lynne Grundy Assistant Director, Research & Development, Betsi Cadwaladr University Health Board Contact details Email Lynne.Grundy@wales.nhs.uk
Dr Lynne Grundy is Assistant Director of R&D at Betsi Cadwaladr University Health Board. Lynne is a Registered Nurse and Registered Midwife and her career has included operational, strategic, education and research roles. She is passionate about embedding research in the NHS and working collaboratively
with partners to develop research opportunities Presentation title: Welcoming commercial research in BCUHB
20
Speakers Professor Dyfrig Hughes BPharm MSc PhD MRPharmS FFRPS FLSW FBPhS Centre for Health Economics & Medicines Evaluation, Bangor University Contact details Telephone +44 (0) 24 8 38 2950 Email d.a.hughes@bangor.ac.uk Dyfrig graduated in pharmacy at Cardiff University before undertaking a PhD in
cardiovascular
pharmacology
at
the
University
of
Liverpool.
He
subsequently trained in health economics, and is currently Professor of Pharmacoeconomics and co-director of the Centre for Health Economics and Medicines Evaluation at Bangor University. He is honorary professor at the Department of Molecular and Clinical Pharmacology, University of Liverpool and is also academic lead for Pharmacy at the Betsi Cadwaladr University Health Board. He has led the pharmacoeconomic activities of the All Wales Therapeutics and Toxicology Centre, contributing to over 200 substantive Health Technology Assessment reports. His main research activities concern pharmaceutical
economics
and
policy,
pragmatic
clinical
trials,
health
technology assessment and medication adherence. He is an editorial board member of the journals PharmacoEconomics and Clinical Pharmacology & Therapeutics. Presentation title: Evidential standards for clinical and cost-effectiveness for NHS adoption
21
Speakers Dr Stephen FĂ´n Hughes CSci FIBMS FHEA Director North Wales & North West Urological Research Centre (NW2URC) HCPC Registered Biomedical Scientist & Chartered Scientist Contact details Telephone +44 (0)1244 513037 Email stephen.hughes@chester.ac.uk Stephen is a Fellow member of the Institute of Biomedical Science (FIBMS), a Fellow member of the Higher Education Academy (FHEA), a Chartered Scientist (Csci) affiliated with the Science Council, and a Biomedical Scientist affiliated with the Health & Care Professions Council (HCPC). He is employed by Betsi Cadwaladr University Health Board
(BCUHB) as a Principal Research Fellow (Biomedical Scientist), based at Wrexham Maelor Hospital, North Wales. In January 2014, Stephen established the North Wales & North West Urological Research Centre (NW2URC) with Co-Director, Mr Iqbal Shergill (Consultant Urological Surgeon). This research centre is the main vehicle for Stephen’s current research work, which primarily involves investigating patients with benign or malignant disorders of the kidneys, bladder and prostate. Presentation title: An Innovative Approach to research and collaborative working: The North Wales & North West Urological Research Centre, Betsi Cadwaladr University Health Board
22
Speakers Dr. Lewis Francis Senior Lecturer Reproductive Biology and Gynaecological Oncology Group Swansea University Medical School Contact details Telephone +44 (0) 1792 602716 Email l.francis@swansea.ac.uk Lewis’s primary area of interest is the functional roles of proteins and their regulatory mechanisms in cell differentiation processes that underpin tissue development and associated pathology. Large protein scaffolds at cell membranes confer specific and wide ranging functional diversity to tissues and are involved in cellular processes such as development, signalling, defence and motility. Epigenetic modifications and their role in differentiation pathways associated
with cancer and progenitor/stem cell differentiation are also a focus, as their crucial role as regulatory landmarks have become more and more apparent. Further understanding these reversible mechanisms of gene and protein regulation, in the context of the wider cellular microenvironment, may well lead to novel biomarker and therapeutic approaches. Active collaborations with materials engineers has enabled us to develop a bio sensing platform which enables the potential translation of these marks through companion diagnostics, the focus of this presentation. Supplement this focus, Dr. Francis has
also
become
heavily
involved
in
the
development
of
advanced
mathematical approaches and software tools for high content data analysis;
ranging from cell imaging, AFM and genomics research data analysis. Presentation title: Multiplex-based biosensing; flexible monitoring of the disease landscape
23
Speakers Prof. David J Snowden The Cynefin Centre for Applied Complexity, Bangor University Contact details Telephone: 01248 351151 Email: d.snowden@bangor.ac.uk Professor Snowden is the founder and Chief Scientific Officer of Cognitive Edge. He has pioneered a science-based approach to organisational decision-making drawing on anthropology, neuroscience and complex adaptive systems theory. He is generally considered to be a pioneer in the application of complex adaptive systems theory to a range of social issues, and in the development of narrative as a research method. His use of the Sensemaker methodology has been applied across government and industry in a variety of fields including
knowledge management, strategic planning, conflict resolution, weak signal detection, decision support and organisational development. Snowden was the Director of IBM's Institute for Knowledge Management, and the founder of the Cynefin Center for Organizational Complexity. During this time, Snowden developed the Cynefin framework, a practical application of complexity theory to management science. The framework helps determine the prevailing operative context, enabling appropriate choices and decisions. Snowden explains the choice of the term Cynefin “[it is] a Welsh word that signifies the multiple factors in our environment and our experience that influence us in ways we can never
understand. Cynefin has a meaning similar to 'habitat' and is also used "as an adjective used to convey 'acquainted' or 'familiar'.� Presentation title: Human sensors: who owns the power of interpretation?
24
Speakers
Dr. Chris Tyson Chris Tyson, Chief Technology Officer at Aparito Contact details Telephone 0845 805 6628 Email chris@aparito.com Chris Tyson is the CTO of Aparito, a company which utilises wearable technology and smart phone apps to change the way patient well-being is monitored. Prior to joining the company, Chris spent over 15 years delivering regulated IT solutions for some of world’s largest pharmaceutical companies
for
clinical,
manufacturing,
regulatory
and
drug
safety
stakeholders. In addition to having a background in software development, Chris also holds an MBA from Manchester Business School. Having deployed our platform to support remote patient monitoring for half a dozen clinical studies on three continents, we’ll discuss the realities of how patients engage with wearable and mobile technologies over long periods of time and what actionable information is captured. Key discussion points include: · Differences in patient engagement based on demographic ·
Operational challenges of supporting patients in the wild
·
Regulatory compliance – Barrier to progress or your best friend?
Presentation title: Digital Health – Beyond the Hype Does app and wearable remote patient monitoring live up to the hype and does it have a future in our healthcare system?
25
Speakers
Prof. Owen J. Guy Centre for Nanohealth, Swansea University Contact details Telephone: (01792) 513181 Email: o.j.guy@swansea.ac.uk
Prof. Owen J Guy (OJG), is Director of the Centre for Nanohealth in the College of Engineering at Swansea University; a unique facility applying device fabrication & cleanroom semiconductor processing to healthcare problems in collaboration with industry. OJG is also head of the Systems Process & Engineering Centre (SPEC) one of 3 research centres within
Swansea’s College of Engineering. OJG’s group has 14 years’ experience in clean room device fabrication (silicon, graphene & MEMS technology). OJG has developed graphene and microfluidics technology through EPSRC grants EP/M006301/1, EP/ G061882/1,
EP/L020734/1
&
EP/I00193X/1,
EP/N013506/1),
KTP
(KTP007901), & TSB / Innovate UK projects (101498). Owen currently leads EPSRC and Marie Curie projects on dementia at Swansea – in collaboration with Plymouth University.
OJG has vast experience of
industrial collaboration under KESS, KTP and Innovate UK (TSB) projects, and has PI grant income of more than £4 million. OJG has published 60
papers, holds 2 patents (WO2011004136 and P100072GB). Presentation title: Lab-on a chip graphene biosensor diagnosis
26
Speakers
Prof. John Draper IBERS, Aberystwyth University, Wales Contact details Tel: +44 (0) 1970 622789 E-mail: jhd@aber.ac.uk
John has worked extensively at the interface between biology, analytical chemistry and computer science. Over the past 10 years he has supervised a range of projects involving metabolic interactions associated with nutrition in humans, domestic animals and biotrophic pathogens of plants. On moving to Aberystwyth in the late 1990’s, John collaborated with colleagues to drive development of a metabolomics technology research platform based on mass spectrometry and machine learning. He currently heads the High Resolution Metabolomics Laboratory (HRML) and has additional responsibility for Enabling Technology in IBERS. The HRML supports public domain resources for high dimensional data processing, automated mining (using machine learning methods) and metabolite identification in mass spectrometry data. Prof. Draper is also the scientific advisor and design lead for a £42M Innovation Campus under development in Aberystwyth, which will provide substantial facilities for translation of food, biotechnology and health-related research programmes, including a £10M Analytical Chemistry facility. Presentation title: Biomarker technology associated with metabolomics (mass spectrometry and machine learning) analysis of urine and blood samples
27
Speakers
Stephen Taaffe PhD student, Bangor University Contact details Tel: +44 (0) 1248382396 E-mail: chu20b@bangor.ac.uk Stephen studied at Bangor from 2013 obtaining his B.Sc. First Class (Hons) in Chemistry in 2016, picking up numerous awards for his academic performance. His final year project was titled “Sugar Coated Clusters� in collaboration with Dr Leigh Jones and Dr Martina Lahmann. Attempting the synthesis of Single Molecular Magnets using protected and functionalised monosaccharide ligands targeted to encapsulate polymetallic clusters.
Stephen has now begun to undertake his Ph.D.
funded by a Knowledge Exploitation Skills Scholarship in the detection of oxacillin resistance in staphylococci. In conjunction with his company partner Sophimark. Presentation title: A lateral flow device for the 21st century
28
Speakers
Dr. Paul Galvin Head of Life Sciences Interface Group, Tyndall Contact details Telephone +353 21 4904030 Email paul.galvin@tyndall.ie
Dr Paul GALVIN is Head of the ICT for Health Programmes and Head of the Life Sciences Interface Group at the Tyndall National Institute. He has a track record of multidisciplinary research, leveraging nano, photonic and ICT enabled platforms to provide novel solutions for healthcare applications. Dr Galvin was awarded his PhD in 1995 and joined the Tyndall National Institute (then NMRC), in 2000. Research within the ICT for Health Programmes in Tyndall is focussed on exploiting the extensive design, fabrication and characterisation tools available in Tyndall, together with expertise in modeling, embedded software and systems integration for applications related to health. This research capacity underpins the development of new collaborative research programmes with leading medical device companies and clinical experts. Dr Galvin initiated, wrote and coordinated a number of large international multidisciplinary research projects such as CF-CHIP (EC FP5 programme â‚Ź2.3 million) and SNiP2CHIP (EC FP6 programme - â‚Ź3.2 million). He was one of the founding members of Nano2Life, the European Network of Excellence (NoE) on Nanobiotechnology. In June 2011, he chaired the Organising Committee for the NanoBioEurope 2011 conference in Cork (Ireland), attended by delegates from 20 countries. Presentation title:
Advanced sensor systems for personalised, predictive, participatory and preventative medicine
29
Speakers
Dr. Stephen Oakeshott Programme Manager for Translational Research, Medical Research Council Contact details Telephone +44 (0) 1793 416236 Email stephen.oakeshott@headoffice.mrc.ac.uk
Steve is one of a team of Programme Managers with responsibility for Translational Research and Industry at the Medical Research Council (MRC). He currently has responsibility for applications seeking to develop innovative medical devices or novel technologies. Prior to joining the MRC, Steve worked as a scientist in academia and biotechnology in the
US, before returning to the UK in 2012 to take up research management position at the MRC.
Presentation title: MRC funding opportunities for device development
30
Speakers Dr. Ann Sudder Innovation Specialist, Department for Economy, Science and Transport, Welsh Government Contact details Telephone 07919 324603 Email Ann.Sudder@wales.gsi.gov.uk After working for 12 years in the petrochemical and coatings industries in management and technical roles, Dr Ann Sudder is now applying her technical and professional expertise as an Innovation Specialist within the Welsh
Government’s
innovation
team
(https://businesswales.gov.wales/
expertisewales/flintshire). The aim of the Welsh Government’s EU funded (ERDF) innovation support for
eligible Welsh businesses is to stimulate and develop economic growth in Wales by encouraging and facilitating businesses and academia to become more competitive by improving their technology base to adopting more innovative management and process practices. Innovation Specialists are a free, confidential resource that support businesses to invest and implement new technologies, carry out R&D and collaborate with other businesses and/ or
research
organisations.
Ann
has
expertise
in
technical
project
management, new product introduction and intellectual property, with specific areas of technical interest being polymer and materials chemistry, coatings research and formulation including design for manufacturing,
photochemistry encompassing catalysis, photovoltaics and photo-degradation plus none disruptive and physical testing of materials. Presentation title: SMART Suite - Commercialisation through R&D
31
Speakers Dr. Martin Champion Portfolio Manager, Medical devices EPSRC Contact details Telephone 01793 444380 Email Martin.Champion@epsrc.ac.uk
Martin
Champion
Healthcare
has
Technology
responsibilities
are
to
been
a
theme manage
portfolio since the
manager
within
October
2014.
Research
Area
His for
EPSRC’s primary Assistive
Technology, Rehabilitation and Musculoskeletal Biomechanics as well as take a broad overview of the Medical Devices portfolio more generally. He is the theme champion for the Frontiers of Physical Intervention Grand Challenge and the interface with the Engineering theme for EPSRC. He also chairs EPSRC Remit query service and helps applicants and colleagues both within EPSRC and other research councils find the most appropriate home for Healthcare focused research proposals.
Presentation title: EPSRC Healthcare Technologies Theme and Investigator led call
32
Notes
33
Notes
34
Notes
35
Notes
36
Notes
37
Notes
38
Notes
39
The School of Chemistry Bangor University Deiniol Road Bangor Gwynedd LL57 2UW Tel: 01248 383741 Email: c.d.gwenin@bangor.ac.uk Personal Web: http://www.gwenin.com Web: http://www.bangor.ac.uk/chemistry Please remember to keep in contact and report any scientific outputs (papers, collaborations etc.)
40